The intravenous formulation of fosfomycin has a novel mechanism of action an no known cross-resistance to other antibiotic ...
The modeling study predicts the rate of drug-resistant BSIs will rise sharply in Europe over the next 5 years, driven ...
Third Quarter 2025 Financial Results: Total revenue for the quarter ended September 30, 2025 was $134.2 million, up 12% from $119.8 million in the same period of 2024. This growth and operational ...
In a significant move highlighting confidence in an innovative biotechnology platform, Renaissance Group LLC has established ...
Health on MSN
The 3 Most Common GLP-1 Injection Sites
Knowing where and how to inject GLP-1s can help ensure you are safely and effectively using the medication. Common sites ...
Subcutaneous therapy could be the future of non–small cell lung cancer (NSCLC) as it would decrease time needed for treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback